Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
Clinical trial NCT06939777 · COMPLETED
Trial details
- NCT number
- NCT06939777
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2025-12-08
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.